Dr Seema Nayak has been a Scientist of Molecular Biology and Immunology at Medanta Hospital, Lucknow since 2019. She received the women scientist fellowship from ICMR HRD-DHR in 2015. She also worked as a Research Officer in the Department of Pathology at King George’s Medical University, Lucknow. She has vast experience in oncology research, biomarkers, advanced Genetics, epigenetics, and molecular and biochemical techniques. Her PhD work was focused on biomarker research in oncology. Her post-doctoral work was on Genomics in Cancer Biomarkers. She has contributed high impact publications in PLOsOne, Oral Oncology journals and in cancer biomarkers and oncology. She is a member of several national and international academic organizations and a reviewer in various international peer reviewed journals. She has been actively involved in cancer diagnostics since 2007. She was the pioneer in starting Cancer biomarker diagnostics based on Immunohistochemistry in India. Dr Anupam Kumar Sriwastava is a Demonstrator in the department of Biochemistry in the All India Institute of Medical Sciences Bathinda, Punjab since 2020. He has a PhD in Biomedical Sciences from King George’s Medical University, Lucknow. He served as Research coordinator in different Phase III Clinical trials and as university representative in entrance exams conducted by KGMU. During his doctoral he did research in reconnoitre and analysis of diagnostic biomarkers for diagnostic and prognostic purposes in urine of cancer patients and published articles in world reputed journals. He also worked as Assistant Professor in Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh and educated the students of B Sc and M Sc classes in different areas of Biotechnology.

• 1. Introduction to tumor diagnostic and prognostic: Differences between conventional and current approaches2. Blood and other body fluid-based biomarkers in tumor cells- Methods and Protocol; A Biochemical and Molecular approaches3: Immunological markers in different cancers; Laboratory testing protocol and pitfalls4. Cancer biomarkers based on liquid biopsies; An update and challenges5. Oral salivary markers in different cancers: Current scenario in techniques and methodology.6. Common childhood cancers: Diagnostic and prognosis markers7. Oncometabolites in tumor cells: Current technique and procedure8. Immunohistochemistry based biomarkers in diagnosis of different types of tumor cells: techniques, procedures and troubleshooting9. Currently available immunohistochemical marker for tumor prognosis and therapeutics10. Molecular markers based on targeted therapy in different tumors11. Circulating tumor cell biomarkers, exosomal markers: Advances and laboratory approaches

Dr Seema Nayak has been a Scientist of Molecular Biology and Immunology at Medanta Hospital, Lucknow since 2019. She received the women scientist fellowship from ICMR HRD-DHR in 2015. She also worked as a Research Officer in the Department of Pathology at King George’s Medical University, Lucknow. She has vast experience in oncology research, biomarkers, advanced Genetics, epigenetics, and molecular and biochemical techniques. Her PhD work was focused on biomarker research in oncology. Her post-doctoral work was on Genomics in Cancer Biomarkers. She has contributed high impact publications in PLOsOne, Oral Oncology journals and in cancer biomarkers and oncology. She is a member of several national and international academic organizations and a reviewer in various international peer reviewed journals. She has been actively involved in cancer diagnostics since 2007. She was the pioneer in starting Cancer biomarker diagnostics based on Immunohistochemistry in India. Dr Anupam Kumar Sriwastava is a Demonstrator in the department of Biochemistry in the All India Institute of Medical Sciences Bathinda, Punjab since 2020. He has a PhD in Biomedical Sciences from King George’s Medical University, Lucknow. He served as Research coordinator in different Phase III Clinical trials and as university representative in entrance exams conducted by KGMU. During his doctoral he did research in reconnoitre and analysis of diagnostic biomarkers for diagnostic and prognostic purposes in urine of cancer patients and published articles in world reputed journals. He also worked as Assistant Professor in Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh and educated the students of B Sc and M Sc classes in different areas of Biotechnology.

• 1. Introduction to tumor diagnostic and prognostic: Differences between conventional and current approaches2. Blood and other body fluid-based biomarkers in tumor cells- Methods and Protocol; A Biochemical and Molecular approaches3: Immunological markers in different cancers; Laboratory testing protocol and pitfalls4. Cancer biomarkers based on liquid biopsies; An update and challenges5. Oral salivary markers in different cancers: Current scenario in techniques and methodology.6. Common childhood cancers: Diagnostic and prognosis markers7. Oncometabolites in tumor cells: Current technique and procedure8. Immunohistochemistry based biomarkers in diagnosis of different types of tumor cells: techniques, procedures and troubleshooting9. Currently available immunohistochemical marker for tumor prognosis and therapeutics10. Molecular markers based on targeted therapy in different tumors11. Circulating tumor cell biomarkers, exosomal markers: Advances and laboratory approaches

Dr Seema Nayak has been a Scientist of Molecular Biology and Immunology at Medanta Hospital, Lucknow since 2019. She received the women scientist fellowship from ICMR HRD-DHR in 2015. She also worked as a Research Officer in the Department of Pathology at King George’s Medical University, Lucknow. She has vast experience in oncology research, biomarkers, advanced Genetics, epigenetics, and molecular and biochemical techniques. Her PhD work was focused on biomarker research in oncology. Her post-doctoral work was on Genomics in Cancer Biomarkers. She has contributed high impact publications in PLOsOne, Oral Oncology journals and in cancer biomarkers and oncology. She is a member of several national and international academic organizations and a reviewer in various international peer reviewed journals. She has been actively involved in cancer diagnostics since 2007. She was the pioneer in starting Cancer biomarker diagnostics based on Immunohistochemistry in India. Dr Anupam Kumar Sriwastava is a Demonstrator in the department of Biochemistry in the All India Institute of Medical Sciences Bathinda, Punjab since 2020. He has a PhD in Biomedical Sciences from King George’s Medical University, Lucknow. He served as Research coordinator in different Phase III Clinical trials and as university representative in entrance exams conducted by KGMU. During his doctoral he did research in reconnoitre and analysis of diagnostic biomarkers for diagnostic and prognostic purposes in urine of cancer patients and published articles in world reputed journals. He also worked as Assistant Professor in Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh and educated the students of B Sc and M Sc classes in different areas of Biotechnology.

• 1. Introduction to tumor diagnostic and prognostic: Differences between conventional and current approaches2. Blood and other body fluid-based biomarkers in tumor cells- Methods and Protocol; A Biochemical and Molecular approaches3: Immunological markers in different cancers; Laboratory testing protocol and pitfalls4. Cancer biomarkers based on liquid biopsies; An update and challenges5. Oral salivary markers in different cancers: Current scenario in techniques and methodology.6. Common childhood cancers: Diagnostic and prognosis markers7. Oncometabolites in tumor cells: Current technique and procedure8. Immunohistochemistry based biomarkers in diagnosis of different types of tumor cells: techniques, procedures and troubleshooting9. Currently available immunohistochemical marker for tumor prognosis and therapeutics10. Molecular markers based on targeted therapy in different tumors11. Circulating tumor cell biomarkers, exosomal markers: Advances and laboratory approaches